BCR inhibitors improving CLL patient outcomes
How to generate an anticancer immune response in multiple myeloma
Highlights from EHA 2016 press briefings: POLLUX and EURO-SKI trials and BiTE antibodies
What are the practical considerations for monoclonal antibody infusion?
Why we need novel strategies for diffuse large B-cell lymphoma